RedHill Biopharma Ltd. announced that it is expanding its commercial management team with several key executive hires ahead of the potential U.S. launch of Talicia®. The Company has appointed Rob Jackson as Vice President of Marketing, Robert J. Gilkin, Jr. as Vice President of Market Access and Steven Thomasian as Vice President of Supply Chain. Rob Jackson, prior to joining RedHill, Mr. Jackson served in commercial leadership roles at Bioventus, most recently as the National Director of Market Access for the surgical business unit. Robert J. Gilkin, Jr., Vice President of Market Access, is an accomplished senior healthcare and pharmaceutical executive with more than 20 years of experience. Mr. Gilkin previously served as a Vice President of Market Access at Synergy Pharmaceuticals, where he was responsible for all aspects of market access and strategy execution for Trulance® (plecanatide). Steven Thomasian, Vice President of Supply Chain brings extensive global experience in supply chain, supplier management and developing alliance and supply chain functionality. Mr. Thomasian most recently held the position of Vice President of Supply Chain at Kala Pharmaceuticals and, prior to that, at Cempra Pharmaceuticals.